Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2023 Jan 23;198(2):383–390. doi: 10.1007/s10549-022-06803-0

Figure 1. DTCs after neoadjuvant therapy vs. age and tumor burden at pretreatment.

Figure 1.

A. Correlation between EPCAM+CD45- cells per mL and age at screening in DTC-positive patients. Correlation coefficient (rho) and p-value were calculated using Spearman’s rank correlation test; B. Association between DTC status and age at screening; C. Association between DTC status and longest tumor diameter by magnetic resonance imaging (MRI) at pretreatment. Means between groups (in B and C) were compared using Wilcoxon signed rank test.